Sangel Biomedical Venture Capital is a Shenzen based venture capital firm investing in biotechnology companies in China and abroad. It was established in 2010 to support high-tech enterprises in China and western countries. The company focuses on biomedicine, medical devices, healthcare, pharmaceutical, and livelihood security. In 2015, Sangel started its first international subsidiary, Sangel Venture Capital Corp in Chicago, United States. As of 2019, the company has made 16 investments in 15 portfolio companies with one successful exit.
Timeline
Funded Companies
Company
Description
Industry
Website
Location
A biopharmaceutical company developing RNA interference-based therapeutics for human diseases
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Company attributes
Industry
Location
Company status
Active
Crunchbase
Pitchbook
